Clinical trial
Efficacy of Intra-Articular Bevacizumab in Preventing Recurrent Hemarthrosis in Hemophilia Patients With Chronic Synovitis: A Pre- and Post-Design Study
NCT07187661 is registered in ClinicalTrials.gov with Khyber Medical University Peshawar as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Intra-Articular Bevacizumab in Preventing Recurrent Hemarthrosis in Hemophilia Patients With Chronic Synovitis: A Pre- and Post-Design Study
- Lead sponsor
- Khyber Medical University Peshawar
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 9, 2025
- Completion date
- April 15, 2026
- Enrollment
- 18 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chronic synovitis, hemophilia